Clin2
NCT06993168Possibly a fitNot yet recruiting

How food affects a new study drug in healthy adults

Healthy

This study tests a new investigational drug (DA-5222) in healthy volunteers to see how food affects its absorption. It helps determine the best way to take the medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You must be a healthy adult.
  • Your body mass index (BMI) must be between 18 and 30.
  • You must weigh at least 50 kg (110 lbs) if you are male, or 45 kg (99 lbs) if you are female.
  • You must not have any significant medical conditions, history of drug abuse, or allergies to medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06993181Not yet recruiting· Phase 1
Comparing a new drug alone and with three components

This early-phase study tests how a new investigational drug (DA-5222) is processed by the body, both when given alone and when combined with three other components. It helps researchers find the right dose and check safety in healthy people.

Seoul, South Korea
NCT07232121Recruiting· Phase 1
Safety study of DF5112 in healthy adults

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Sydney, New South Wales
NCT06976489Not yet recruiting· Phase 1
Effect of food on a new drug in healthy volunteers

This study looks at how taking the study drug PA-111 with food changes how it is absorbed and how safe it is in healthy people. It helps researchers understand the best way to take the medication.

Seoul
NCT07349589Not yet recruiting· Phase 1
Safety study of an investigational drug in healthy adults

This study tests a new investigational drug to see if it is safe and how the body processes it. It is for healthy adults who are willing to participate in a closely monitored clinical trial.

Cheongju-si
NCT07691242Not yet recruiting· Phase 1
Study of a new drug for healthy adults

This trial is testing a new medication called DW4421. It's an early-stage study to see how safe the drug is and how it affects healthy people. Participants will receive the drug multiple times to help doctors understand dosing.

Cheongju-si, North Chungcheong
NCT07364877Enrolling by invitation· Phase 1
Safety study of DW4421 and DW4421S in healthy adults

This trial tests two forms of a new drug, DW4421 and DW4421S, to see how safe they are and how the body processes them. It is for healthy volunteers aged 19 to 50.

Cheongju-si

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.